| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.90 | $3.42 | $3.74 | $3.83 | $3.82 | $0.83 | $0.87 | $0.85 |
| EPS (Diluted) | $3.88 | $3.41 | $3.73 | $3.81 | $3.81 | $0.83 | $0.87 | $0.85 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.0B | $18.3B | $18.4B | $17.9B | $15.5B | $14.1B | $12.5B | $9.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.2B | $0.1B |
| Total Liabilities | $16.6B | $16.0B | $16.2B | $15.9B | $13.5B | $12.2B | $10.7B | $8.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.5B | $2.3B | $2.2B | $2.0B | $1.9B | $1.9B | $1.8B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.8B | $-0.3B | $-0.3B | $-0.4B | $-1.5B | $-1.6B | $-1.0B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.5B | $-0.0B | $0.1B | $0.1B | $1.2B | $1.4B | $0.9B | $0.4B |